Caribou Biosciences
Price & Volume
Stats
See more52W Range | $0.66-$3.53 |
Market Cap | $147.6M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $9.2M |
Revenue Growth (YoY) | 8.6% |
Gross Profit (12 Mos) | -$119.2M |
Diluted EPS | -$1.70 |
News
See moreYahoo Finance • 22 days ago
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
Yahoo Finance • last month
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025
Yahoo Finance • 2 months ago
Caribou Bioscience GAAP EPS of -$0.30 beats by $0.07, revenue of $2.2M misses by $0.07M
Yahoo Finance • 2 months ago
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
About
CEO | Dr. Rachel E. Haurwitz Ph.D. |
Address | 2929 7th Street, Berkeley, CA, United States, 94710 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 147 |
